HuiYin296 personal page - To The Moon

HuiYin296

HuiYin296

No personal profile

70Follow

5Followers

0Topic

0Badge

2021-07-09

?

Sorry, the original content has been removed

2021-07-14

..

Sorry, the original content has been removed

2021-07-09

??

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3586462546387284","uuid":"3586462546387284","gmtCreate":1623368731438,"gmtModify":1625796877511,"name":"HuiYin296","pinyin":"huiyin296","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/14138ba07671079f0f27a369bf95544c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":70,"tweetSize":15,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.07.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":145698101,"gmtCreate":1626220223403,"gmtModify":1703755647088,"author":{"id":"3586462546387284","authorId":"3586462546387284","name":"HuiYin296","avatar":"https://static.tigerbbs.com/14138ba07671079f0f27a369bf95544c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586462546387284","idStr":"3586462546387284"},"themes":[],"title":"","htmlText":"..","listText":"..","text":"..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/145698101","repostId":"1192342859","repostType":4,"isVote":1,"tweetType":1,"viewCount":2220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143854947,"gmtCreate":1625789106889,"gmtModify":1703748474456,"author":{"id":"3586462546387284","authorId":"3586462546387284","name":"HuiYin296","avatar":"https://static.tigerbbs.com/14138ba07671079f0f27a369bf95544c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586462546387284","idStr":"3586462546387284"},"themes":[],"title":"","htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143854947","repostId":"2150267623","repostType":4,"isVote":1,"tweetType":1,"viewCount":1921,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143852513,"gmtCreate":1625789048032,"gmtModify":1703748472517,"author":{"id":"3586462546387284","authorId":"3586462546387284","name":"HuiYin296","avatar":"https://static.tigerbbs.com/14138ba07671079f0f27a369bf95544c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586462546387284","idStr":"3586462546387284"},"themes":[],"title":"","htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143852513","repostId":"1106457456","repostType":4,"repost":{"id":"1106457456","kind":"news","pubTimestamp":1625786090,"share":"https://ttm.financial/m/news/1106457456?lang=en_US&edition=fundamental","pubTime":"2021-07-09 07:14","market":"us","language":"zh","title":"Pfizer develops COVID vaccine booster to tackle Delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1106457456","media":"新浪财经","summary":"辉瑞及其合作伙伴BioNTech周四宣布，他们正开发一种针对“德尔塔”变种病毒的新冠疫苗增强剂，因为人们越来越担心这种高度传染性的毒株已经成为美国新冠病毒的主要毒株。\n两家公司表示，尽管他们认为目前的","content":"<p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>and its partner BioNTech announced Thursday that they are developing a COVID vaccine booster against the \"Delta\" variant of the virus amid growing concerns that the highly contagious strain has become the dominant coronavirus strain in the United States.</p><p>The companies said that while they believe the current two-dose vaccine has the potential to maintain \"the highest level\" of protection against all known variants, including Delta, if given a third dose, they are still \"on their toes\" and are developing an updated version of the vaccine.</p><p>The companies said clinical studies could begin as early as August, subject to regulatory approval.</p>","source":"XLCJ","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer develops COVID vaccine booster to tackle Delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer develops COVID vaccine booster to tackle Delta variant\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">新浪财经</strong><span class=\"h-time small\">2021-07-09 07:14</span>\n</p>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>and its partner BioNTech announced Thursday that they are developing a COVID vaccine booster against the \"Delta\" variant of the virus amid growing concerns that the highly contagious strain has become the dominant coronavirus strain in the United States.</p><p>The companies said that while they believe the current two-dose vaccine has the potential to maintain \"the highest level\" of protection against all known variants, including Delta, if given a third dose, they are still \"on their toes\" and are developing an updated version of the vaccine.</p><p>The companies said clinical studies could begin as early as August, subject to regulatory approval.</p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-07-09/doc-ikqcfnca5780249.shtml\">新浪财经</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f78fc8716e758c96a05271f4a9570166","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-07-09/doc-ikqcfnca5780249.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106457456","content_text":"辉瑞及其合作伙伴BioNTech周四宣布，他们正开发一种针对“德尔塔”变种病毒的新冠疫苗增强剂，因为人们越来越担心这种高度传染性的毒株已经成为美国新冠病毒的主要毒株。\n两家公司表示，尽管他们认为目前的两剂疫苗如果施打第三剂有可能对包括德尔塔在内的所有已知变种保持“最高水平”的保护，但他们仍在“保持警惕”，并正在开发一种更新版本的疫苗。\n两家公司表示，临床研究最早可能于8月开始，但需获得监管机构的批准。","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2399,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":143854947,"gmtCreate":1625789106889,"gmtModify":1703748474456,"author":{"id":"3586462546387284","authorId":"3586462546387284","name":"HuiYin296","avatar":"https://static.tigerbbs.com/14138ba07671079f0f27a369bf95544c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586462546387284","authorIdStr":"3586462546387284"},"themes":[],"title":"","htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143854947","repostId":"2150267623","repostType":4,"isVote":1,"tweetType":1,"viewCount":1921,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":145698101,"gmtCreate":1626220223403,"gmtModify":1703755647088,"author":{"id":"3586462546387284","authorId":"3586462546387284","name":"HuiYin296","avatar":"https://static.tigerbbs.com/14138ba07671079f0f27a369bf95544c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586462546387284","authorIdStr":"3586462546387284"},"themes":[],"title":"","htmlText":"..","listText":"..","text":"..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/145698101","repostId":"1192342859","repostType":4,"isVote":1,"tweetType":1,"viewCount":2220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143852513,"gmtCreate":1625789048032,"gmtModify":1703748472517,"author":{"id":"3586462546387284","authorId":"3586462546387284","name":"HuiYin296","avatar":"https://static.tigerbbs.com/14138ba07671079f0f27a369bf95544c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586462546387284","authorIdStr":"3586462546387284"},"themes":[],"title":"","htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143852513","repostId":"1106457456","repostType":4,"isVote":1,"tweetType":1,"viewCount":2399,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}